FDA Approval Activities for this Drug…

Innohep (tinzaparin sodium) Injection, Bristol-Myers Squibb Pharma Company NDA 20-484/S-002 2/5/02 4/17/02 Innohep (tinzaparin sodium) Injection, Dupont Pharmaceutical Company NDA 20-484 7/14/00 7/24/00 7/24/00 4/9/02 Innohep Indications: for the treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin sodium.

For the latest approval information and links for this API, please see the main page.